Create account

Coverage dated October 21, 2026

Abbott plans to spin off nutrition unit that generates $8.5 billion in annual sales

Headline from Quartz

The separation of the maker of Similac and Ensure is expected by the end of 2027 and will leave 2026 guidance unchanged

Quartz's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

4 articles, oldest first.

  1. Bloomberg

    Abbott Spins Off Embattled Business That Sells Baby Formula (opens Bloomberg)

    Published

    Bloomberg's feed description

    Abbott Laboratories said it plans to spin off its nutrition unit into a separate publicly traded company after a series of missteps have weighed on the company’s broader performance.

  2. Independent Journal Review

    Abbott Plans $8.5 Billion Nutrition Business Spinoff (opens Independent Journal Review)

    Published

    Independent Journal Review's feed description

    Abbott plans to spin off its roughly $8.5 billion-a-year nutrition business, including brands such as Similac and Ensure, as a separately traded company by the end of 2027, with shareholders owning stakes in both companies.

  3. Quartz

    Abbott plans to spin off nutrition unit that generates $8.5 billion in annual sales (opens Quartz)

    Published

    Quartz's feed description

    The separation of the maker of Similac and Ensure is expected by the end of 2027 and will leave 2026 guidance unchanged

  4. Investor's Business Daily

    Abbott Topples After Announcing Plans To Spin Off Its Nutrition Business (opens Investor's Business Daily)

    Published

    Investor's Business Daily's feed description

    Abbott stock took a hit Wednesday after the healthcare company said it plans to spin off its nutrition business.

Abbott plans to spin off nutrition unit that generates $8.5 billion in annual sales | Since Then